David James Ballance's Net Worth

-$6.7 Thousand

Estimate Recalculated Sep 8, 2024 07:33PM EST

Who is David James Ballance?

David James Ballance does not have any significant net worth to report based on the numbers we have. This is based on reported shares in PhaseBio Pharmaceuticals Inc.

SEC CIK

David James Ballance's CIK is 0001755432

Past Insider Trading and Trends

2020 was David James Ballance's most active year for acquiring shares with 2 total transactions. David James Ballance's most active month to acquire stocks was the month of January. 2018 saw David James Ballance paying a total of $3,940.00 for 1,000 shares, this is the most they've acquired in one year.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

PhaseBio Pharmaceuticals Inc (PHASQ) Snapshot price: $0.000001

VP, Research and Sci. Affairs

David James Ballance owns 8,519 units of Common Stock which is worth $0.01. In the year 2018 David James Ballance filed a total of 6 filings.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+12.09%
919
$3.00
$2,757.00
8.52K
Nov 20
Form 4
—
0
—
—
0
Feb 12
Form 4
—
0
—
—
0
Feb 27
Form 4
+15.15%
1K
$3.94
$3,940.00
7.6K
Dec 13
Form 3/A
—
0
—
—
0
Form 3
—
0
—
—
0
No matching records found